Found: 6
Select item for more details and to access through your institution.
Crizotinib inhibits the metabolism of tramadol by non-competitive suppressing the activities of CYP2D1 and CYP3A2.
- Published in:
- PeerJ, 2024, p. 1, doi. 10.7717/peerj.17446
- By:
- Publication type:
- Article
The effect of icotinib or apatinib on the pharmacokinetic profile of oxycodone in rats and the underlying mechanism.
- Published in:
- PeerJ, 2023, p. 1, doi. 10.7717/peerj.16601
- By:
- Publication type:
- Article
Functional evaluation of cyclosporine metabolism by CYP3A4 variants and potential drug interactions.
- Published in:
- Frontiers in Pharmacology, 2023, v. 13, p. 1, doi. 10.3389/fphar.2022.1044817
- By:
- Publication type:
- Article
Inhibitory effects of fluoxetine and duloxetine on the pharmacokinetics of metoprolol in vivo and in vitro.
- Published in:
- Fundamental & Clinical Pharmacology, 2022, v. 36, n. 6, p. 1057, doi. 10.1111/fcp.12795
- By:
- Publication type:
- Article
CYP2D6 gene polymorphism and apatinib affect the metabolic profile of fluvoxamine.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.985159
- By:
- Publication type:
- Article
The Influence of CYP3A4 Genetic Polymorphism and Proton Pump Inhibitors on Osimertinib Metabolism.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.794931
- By:
- Publication type:
- Article